Expression and amplification of glutamine synthetase gene endows HepG2 cells with ammonia-metabolizing activity for bioartificial liver support system

被引:7
|
作者
Omasa, T
Yamanaka, M
Tanimura, N
Katakura, Y
Kishimoto, M
Suga, K
Enosawa, S
机构
[1] Osaka Univ, Dept Biotechnol, Suita, Osaka 5650871, Japan
[2] Natl Res Inst Child Hlth & Dev, Setagaya Ku, Tokyo 1548509, Japan
关键词
ammonia-metabolizing activity; HepG2; cell; CHO; bioartificial liver support system; gene amplification;
D O I
10.1016/j.enzmictec.2004.08.027
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To establish the ammonia-metabolizing cell lines for a bioartificial liver support system, CHO-K1 and HepG2 were transformed with pBK-CMV-GS vector that contains glutamine synthetase (gs) gene. The recombinant cell lines were selected under the various concentrations of glutamine synthetase inhibitor, methionine sulfoximine (MSX). The host CHO-K1 and HepG2 cell lines produces ammonia, but the both MSX tolerable CHO (GS-CHO) and HepG2 (GS-HepG2) cell lines endowed with the high GS activity could metabolize the ammonium from medium. The ammonia-metabolizing activity of CHO and HepG2 cell was about one-fourth of that of primary hepatocyte. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [1] Expression and amplification of glutamine synthetase gene for constructing ammonia-metabolizing cell lines in hybrid bioartificial liver support system
    Omasa, T
    Kim, K
    Hiramatsu, S
    Katakura, Y
    Kishimoto, N
    Matsumura, T
    Enosawa, S
    Suzuki, S
    Amemiya, H
    Suga, K
    ANIMAL CELL TECHNOLOGY : BASIC & APPLIED ASPECTS, VOL 12, 2002, : 263 - 267
  • [3] Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase
    Tang, Nan-Hong
    Wang, Xiao-Qian
    Li, Xiu-Jin
    Chen, Yan-Ling
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2008, 7 (06) : 621 - 627
  • [4] Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2
    Miyashita, T
    Enosawa, S
    Suzuki, S
    Tamura, A
    Tanaka, H
    Amemiya, H
    Matsumura, T
    Omasa, T
    Suga, K
    Aoki, T
    Koyanagi, Y
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 2355 - 2358
  • [5] Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver
    Enosawa, S
    Miyashita, T
    Suzuki, S
    Li, XK
    Tsunoda, M
    Amemiya, H
    Yamanaka, M
    Hiramatsu, S
    Tanimura, N
    Omasa, T
    Suga, K
    Matsumura, T
    CELL TRANSPLANTATION, 2000, 9 (05) : 711 - 715
  • [6] Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2
    Enosawa, S
    Miyashita, T
    Tanaka, H
    Li, XK
    Suzuki, S
    Amemiya, H
    Omasa, T
    Suga, K
    Matsumura, T
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1945 - 1947
  • [7] Alterations in gene expression by trivalent chromium in HepG2 cells and mouse liver.
    Baldwin, W
    Bain, L
    Romero, B
    TOXICOLOGICAL SCIENCES, 2003, 72 : 263 - 264
  • [8] Porous and single-skinned polyethersulfone membranes support the growth of HepG2 cells: A potential biomaterial for bioartificial liver systems
    Zhang, Shi-Chang
    Liu, Tao
    Wang, Ying-Jie
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2012, 27 (03) : 359 - 366
  • [9] Comparative Effects of Fructose and Glucose on Lipogenic Gene Expression and Intermediary Metabolism in HepG2 Liver Cells
    Hirahatake, Kristin M.
    Meissen, John K.
    Fiehn, Oliver
    Adams, Sean H.
    PLOS ONE, 2011, 6 (11):
  • [10] Xanthohumol Suppresses Mylip/Idol Gene Expression and Modulates LDLR Abundance and Activity in HepG2 Cells
    Chen, Shih-Fen
    Chen, Pei-Yi
    Hsu, Hao-Jen
    Wu, Ming-Jiuan
    Yen, Jui-Hung
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (36) : 7908 - 7918